Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)

Clinical trial NCT01890434 · COMPLETED

Trial details

NCT number: NCT01890434
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2013-08-26
Primary completion: 2016-08-06
Enrollment: 478

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.